Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Novartis
Medtronic
Queensland Health
Fuji
Chinese Patent Office
Deloitte
Moodys
QuintilesIMS
Daiichi Sankyo

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,608,075

« Back to Dashboard

Summary for Patent: 5,608,075
Title: Polymorphs of losartan and the process for the preparation of form II of losartan
Abstract:Polymorphic forms of Losartan (Formula I) ##STR1## and a process for the preparation of Form II of Losartan. Losartan is known to be useful in the treatment of hypertension.
Inventor(s): Campbell, Jr.; Gordon C. (Wilmington, DE), Dwivedi; Anil M. (Newark, DE), Levorse; Dorothy A. (South Amboy, NJ), McCauley; James A. (Bellemeade, NJ), Raghavan; Krishnaswamy S. (Wilmington, DE)
Assignee: Merck & Co., Inc. (Rahway, NJ) E. I. Du Pont de Nemours & Company (Wilmington, DE) The DuPont Merck Pharmaceutical Company (Wilmington, DE)
Application Number:08/371,937
Patent Claim Types:
see list of patent claims
Process;

Drugs Protected by US Patent 5,608,075

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,608,075

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 1405895 ➤ Subscribe
Australia 685898 ➤ Subscribe
Canada 2179067 ➤ Subscribe
European Patent Office 0736021 ➤ Subscribe
Japan H09507075 ➤ Subscribe
World Intellectual Property Organization (WIPO) 9517396 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
US Department of Justice
Cerilliant
Medtronic
Chinese Patent Office
Accenture
US Army
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot